Welcome to YLOAN.COM
yloan.com » Health » Immunovaccine Technologies Inc. (imv) - Financial And Strategic Analysis Review --- Aarkstore
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Immunovaccine Technologies Inc. (imv) - Financial And Strategic Analysis Review --- Aarkstore

ImmunoVaccine Technologies Inc

ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic Analysis Review

ImmunoVaccine Technologies Inc. (IMV, formerly Rhino Resources Inc.) is a biotechnology company engaged in the development of high potential vaccines used for human health. The company develops its products based on its unique patented vaccine delivery and enhancement technology, the DepoVax platform, which is also being licensed to Pfizer Animal Health. The company develops vaccines for cancer, infectious disease and other vaccines. Its lead product, DPX-0907 is a therapeutic vaccine that is used against ovarian, breast and prostate cancers. Recently, the company entered into an agreement with National Cancer Institute (NCI) for the development of DepoVax.

ImmunoVaccine Technologies Inc. Key Recent Developments

May 17, 2010: Immunovaccine Names Paul Kirkconnell To Board


May 12, 2010: Immunovaccine Reports Net Loss Of $1.5 Million For Q1 2010

Apr 22, 2010: Immunovaccine Signs Research Agreement With Dana-Farber Cancer Institute

Apr 06, 2010: Immunovaccine Publishes DPX-0907 Preclinical Study

Feb 23, 2010: Immunovaccine Names James Hall As New Board Member

This comprehensive SWOT profile of ImmunoVaccine Technologies Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ImmunoVaccine Technologies Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.


- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information please visit :

http://www.aarkstore.com/reports/ImmunoVaccine-Technologies-Inc-IMV-Financial-and-Strategic-Analysis-Review-51988.html

by: Aarkstore Enterprise
Antioxidants Help Arteries Stay Healthy In People At Risk For Heart Disease Top Ten Ways To Improved Health And Fitness Learn How To Know When You Have Insomnia Do You Have An Unhealthy Brain? Breast Implants And The Female Body Image What Keeps Children Healthy? Effective Dental Care And Risks Of Poor Dental Health Bio-technology Herbal Treatment For Diabetes Have You Ever Wondered How Your Body Can Be Coaxed In To Burn Fat Quickly? Kettlebell Exercises A Surefire Way To Total Body Fitness Hemorrhoids Relief - Top Herbal Remedies To Try Improve Your Health With A Steam Shower Or Steam Room Pregnancy Symptoms By Week - What Can I Expect In Week 1?
print
www.yloan.com guest:  register | login | search IP(216.73.216.7) California / Anaheim Processed in 0.017891 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 52 , 3855, 61,
Immunovaccine Technologies Inc. (imv) - Financial And Strategic Analysis Review --- Aarkstore Anaheim